A new target for chronic asthma
Nature Medicine
April 18, 2011
Blocking the immune cell protein LIGHT in the lungs prevents airway remodeling in a mouse model of asthma, reports research published online this week in Nature Medicine. The study suggests that targeting this pathway may prevent breathing problems that develop due to asthma-related airway remodeling.
Patients with severe asthma exhibit chronic unresolved inflammation in the lungs leading to remodeling of the airways, fibrosis, and decreased lung function. Despite controlling airway inflammation, current therapies used to treat asthma have little effect on remodeling. Michael Croft and colleagues find that the protein LIGHT is expressed on activated immune cells after exposure to allergens from house dust mites and promotes airway remodeling. Genetic and antibody-mediated blockade of LIGHT prevents remodeling and decreased lung function as a result of allergen exposure, without altering the influx of immune cells into the lung.
doi: 10.1038/nm.2356
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature